Showing posts with label Medications. Show all posts
Showing posts with label Medications. Show all posts

Monday, November 29, 2010

Hip Replacement Improves Function, Saves Money

Seniors with osteoarthritis who undergo total hip replacement are twice as likely as those who do not to show improvements in physical functioning and increased ability to care for themselves, according to researchers at Duke University Medical Center. The study, which is the largest of its kind conducted to date, found that there is no age limit on the benefits of hip replacement for patients.
Researchers found that total hip replacements provide a cost savings to the health care system because reimbursement for the procedure (averaging $4,000 – $6,000) proves less costly than the long-term cost of health care for the disabled.
In addition to improved quality of life, health economists estimate savings associated with a year of a disability-free life at approximately $50,000, including all related health-care costs incurred by disabled patients such as hospital stays, nursing homes and home health care.
"We found that total hip arthroplasty improves everyday life for patients and is as beneficial to people in their 80s or 90s as it is for someone in their 60s," said Linda George, Ph.D., professor of Sociology and associate director of the Duke Center for the Study of Aging. "While the number of surgeries conducted in the U.S. has increased dramatically over the last decade, fewer than 25 percent of patients who could benefit from the procedure elect to receive it."
Osteoarthritis of the hip is a progressive type of arthritis closely associated with aging and obesity. It affects about 10 million Americans, causing pain, decreased mobility and increased risk of falls and fractures. Generally, non-surgical treatment is first recommended to reduce joint pain and inflammation and improve joint function. Hip replacements are performed when less invasive forms of treatment — medications and physical therapy — have failed.
"Osteoarthritis of the hip has a devastating impact on a patient’s quality and length of life. Our study aimed to understand how total hip replacements affect tasks people do in their everyday lives, such as bathing, dressing, walking a few blocks, shopping and preparing meals," George said.
Patients who were disabled at the time of surgery had transitioned out of disability within one year of the procedure.
Total hip replacement is an invasive treatment with a long rehabilitation period. According to Dr. George, this may help explain why physicians are less likely to present surgery as an option to those patients 85 years of age and older, and why there may be some reluctance among patients to choose the procedure.
"Physicians are less likely to present this option to the very old," George said, "but they should feel confident in recommending this procedure to those who are eligible for it."
"We know that hip replacements are relatively safe and reports have shown a very high rate of patient satisfaction due to reduced pain and increased range of motion," she added.

Tuesday, November 16, 2010

Do Doctors Have Pharmaceutical Best Interest in Mind

Does your doctor have you or the pharmaceutical company’s best interest in mind? Well according to reports from a joint investigation by news agencies and non-profit groups; found that more than 380 of the health care workers took in more than $100,000 in 2009 and 2010.
The report showed than 17,000 healthcare providers, including doctors, have received money from several major drug companies to talk to other doctors about their products.
The payments are not illegal showed that doctors were sometimes urged to recommend “off-label” prescriptions, meaning using them for conditions they are not approved for showing that some doctors have something else in mind besides patients best interest.
The report also calls into question the impact that drug company payments might have on doctors when they prescribe medications. Several lawsuits have accused drug companies of paying doctors to prescribe certain drugs. In a recent New York Times there was a story about those lawsuits, specifically ones focusing on anti-psychotic drugs.
Thousands and thousands of US physicians are paid by pharmaceutical companies to spread the word about their “favored pills and to advise the companies about research and marketing,” the group said in the report.
The investigation included information from seven drug makers -- AstraZeneca, Cephalon, GlaxoSmithKline, Johnson & Johnson, Eli Lilly, Merck and Pfizer. Consumer Reports said the information was released voluntarily by some of the companies, while some “were forced to disclose this information as a result of legal settlements.”
This is becoming such a problem that in the 2nd annual prescription drug survey conducted by Consumer Reports National Research Center they found that after they surveyed more than 1,150 adults who currently take prescription drugs, that 69 percent of those polled think drug companies have too much influence on medications doctors prescribe.
Dr. John Santa, director of the Consumer Reports Health Ratings Center, said in a statement that “the amount of money involved is astounding, and the ProPublica report's account of the background of some of the physicians is disturbing.”
It is important to note that not all doctors have received money from several major drug companies to talk to other doctors about their products.